Project 2

Project 2

Goal & Research Areas

Identification of novel targets, therapeutic strategies, and nucleic acid delivery methods to combat SARS-CoV-2 and enterovirus 71

Core Leader & Team

Peter Sarnow

Peter Sarnow

Learn More Learn More
James Dahlman

James Dahlman

Learn More Learn More
Stan Cohen

Stanley Cohen

Learn More Learn More
Matt Disney

Matt Disney

Learn More Learn More
Phil Santangelo

Phil Santangelo

Learn More Learn More

Hot Topic

Jeffrey Glenn receives $69 million to start antiviral drug-discovery center at Stanford

Jeffrey Glenn receives $69 million to start antiviral drug-discovery center at Stanford

The National Institute for Allergy and Infectious Diseases has awarded Jeffrey Glenn, MD, PhD, professor of hepatology and gastroenterology and of microbiology and immunology, $69 million...

Read More Learn More
Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial

Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial

A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.

Read More Learn More
Antiviral Program for Pandemics

Antiviral Program for Pandemics

The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2, the virus that causes COVID-19, as well as to build sustainable platforms for targeted drug discovery and development of a robust pipeline of antivirals against viruses with pandemic potential.

Read More Learn More
Peter Sarnow
Peter Sarnow Ph.D., Stanford University Fellow, Division of Gastroenterology and Hepatology, Stanford University School of Medicine

Director of Graduate Program, Department of Microbiology & Immunology, Stanford University School of Medicine (2002-Present)Member of the Committee on Graduate Studies, Stanford University (2001-2004)Member of School of Medicine Awards Committee, Stanford University School of Medicine (2005-Present)Chair, Dept. of Microbiology & Immunology, Stanford University School of Medicine (2010-2017)